Cannara Biotech Inc. Reports Q4 and Fiscal Year 2024 Results: Achieves Record Sales Growth and Operating Cash Flow, Solidifying Leadership in Canada's Cannabis Market
November 25, 2024 09:30 ET
|
Cannara Biotech (Québec) Inc.
Cannara Biotech reports record FY2024 revenue of $82.2M (+43%), strong Q4 growth, 3.2% national market share, and plans for expanded production.
OxySure (OXYS) Improves Bottom Line as It Ramps Up Revenues
August 21, 2012 08:53 ET
|
OxySure Systems, Inc.
FRISCO, Texas, Aug. 21, 2012 (GLOBE NEWSWIRE) -- OxySure Systems Inc. (OTCBB:OXYS), a medical technology company focused on the design, manufacture and distribution of specialty medical and...